SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-22-181616
Filing Date
2022-06-24
Accepted
2022-06-24 17:01:00
Documents
12
Period of Report
2022-06-21
Items
Item 5.07: Submission of Matters to a Vote of Security Holders

Document Format Files

Seq Description Document Type Size
1 8-K d370740d8k.htm   iXBRL 8-K 28961
  Complete submission text file 0001193125-22-181616.txt   150578

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA igms-20220621.xsd EX-101.SCH 2843
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE igms-20220621_lab.xml EX-101.LAB 17980
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE igms-20220621_pre.xml EX-101.PRE 11250
6 EXTRACTED XBRL INSTANCE DOCUMENT d370740d8k_htm.xml XML 3351
Mailing Address 325 E MIDDLEFIELD ROAD MOUNTAIN VIEW CA 94043
Business Address 325 E MIDDLEFIELD ROAD MOUNTAIN VIEW CA 94043 650-965-7873
IGM Biosciences, Inc. (Filer) CIK: 0001496323 (see all company filings)

IRS No.: 770349194 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39045 | Film No.: 221040826
SIC: 2834 Pharmaceutical Preparations